OrbiMed backs Pee Safe in $32 million primary and secondary deal
The hygiene brand plans to expand retail distribution and online sales channels.
Pee Safe announced a $32 million transaction with OrbiMed on 14 January 2026. The deal combines new investment and secondary share sales; the company did not disclose the amount of fresh capital.
The personal hygiene brand plans to expand offline distribution, strengthen marketing and increase its presence on quick commerce platforms and marketplaces.
Pee Safe’s portfolio spans toilet hygiene, menstrual and intimate care, grooming and sexual wellness. Transaction counsel said the primary investment was structured in three tranches.
Use of funds
Offline retail distribution
Brand marketing
Quick commerce and marketplaces